What's Happening?
The START Center for Cancer Research has appointed Dr. Neel Belani as a Clinical Investigator at its New Jersey site. Dr. Belani, a board-certified medical oncologist, will lead early-phase oncology trials, expanding access to innovative cancer therapies.
His appointment is part of START's collaboration with Astera Cancer Care, aiming to serve a large patient population in New Jersey. Dr. Belani brings extensive experience in clinical trials and a commitment to patient-centered care, enhancing START's capabilities in delivering high-quality studies.
Why It's Important?
This appointment strengthens START's position in the competitive field of oncology research, particularly in a densely populated area like New Jersey. By expanding access to early-phase clinical trials, START is poised to accelerate the development of new cancer therapies, potentially benefiting thousands of patients. Dr. Belani's leadership could lead to more efficient trial execution and faster access to cutting-edge treatments, which is crucial in the fight against cancer.
What's Next?
Dr. Belani will work closely with the existing research team to enhance the site's capabilities and increase patient enrollment in clinical trials. This collaboration may lead to more partnerships with other oncology practices, further expanding START's reach. The focus will be on maintaining high standards in trial execution and ensuring that patients have access to the latest therapeutic options.
